A reference to global access — the development of technologies from Harvard patents can lead to licensed products that could have significant public health benefits in developing countries. By participating in universities Allied for Essential Medicines, Harvard is committed to promoting affordable access to these products in developing countries. To fulfill this obligation, we may require provisions similar to those contained in the link below in exclusive licenses for such potentially effective technologies. To view standard confidentiality agreements, material transfer agreements or research cooperation agreements, please return to our Model Agreements page. A license for Harvard`s own patent rights is subject to conditions similar to those set forth in the form agreements in the following links. Some terms can be changed to address unique aspects of each situation. In particular, financial conditions shall be determined on the basis of the technology to be granted, the licensee`s business model and market standards in the sector in which the licensee operates. 7.3 This clause 7 shall survive the termination of this Agreement. For the use of [Description of what is allowed].
18.1 This Agreement contains the entire agreement between the parties and supersedes all prior agreements, obligations or agreements, whether oral or written. In addition, this Agreement may not be modified, modified or otherwise modified unless it is a written agreement signed by both parties. This type of agreement allows Harvard researchers who are starting a new company to license non-patentable, copyrighted software they have developed as part of faculty research efforts. In cases where there is patentable content such as unique algorithms, please read the “Basic Exclusive License” model agreement published above. one. if licensee violates any provision of this License Agreement and has not corrected such breach within 7 days of Licensor`s notification to the reasonable satisfaction of Licensor; b. where the licensee becomes insolvent or initiates bankruptcy, insolvency, reorganization or dissolution proceedings (or is the subject of an action against him) or pre-benefiting from an assignment for the benefit of creditors; or c. the licensee violates clause 5 or 7 of this Agreement. 1.4 “intellectual property rights” means all rights in and to copyrights, trademarks, trade names, designs, patents, know-how (trade secrets) and any other rights arising from intellectual activity in the industrial, scientific, literary or artistic fields, as well as any request or right to apply for registration of any of these rights and any right to protect or enforce any of these rights; as specified in clause 5. Harvard also offers option agreements for companies considering licensing a Harvard technology.
An option agreement allows a company to “retain” a technology for a short period of time, during which time the company can continue to assess its potential or raise funds for product development without binding on the obligations of a licensing agreement or Harvard. Options typically have a term of six months to one year and typically require both a pre-fee and a refund of the patent application for the duration of the option. Access to innovation at Harvard should be as simple as possible. Our licensing agreements are fair and reasonable, and experienced OTD employees work with you to help you achieve your business goals. To give you an idea of how these licenses take shape, we are happy to provide you here with a number of eloquent model agreements. . . .